Neurogenetic Testing Market Segmented By MRI, Next generation sequencing, Multiplex ligation-dependent probe amplification (MLPA) and Fragment analysis PCR Technique
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP32899
According to the latest research by Persistence Market Research, the neurogenetic testing market is set to witness positive growth of CAGR 7% during 2021-2031. Any defect in one or more genes affecting the nervous system causes neurogenetic disorder.
These may include dementia, hereditary neuropathy, Parkinson disease, Epileptic disorders, etc. The Neurogenetic Testing market is majorly driven by advancements in DNA sequencing techniques and increasing research in the life science domain. These method provide an accurate course of treatment of the disorder.
The major drivers demand for neurogenetic testing are increasing prevalence of neurological diseases, awareness among common population about genetic screening, availability of modern diagnostic methods and increasing life science R&D. Various technological advancements are happening in DNA sequencing. Currently the method used for DNA sequencing is next-generation sequencing.
Another driver is the prevalence of various neurological disorders. According to a WHO report, the European region contribute 11.2% of global burden of neurological disorder followed by Western Pacific region with 10%. According to a report, the number of deaths caused by neurological disorder is increased by 39% in the past 30 years.
This increase in the prevalence therefore acts as a driven for neurological testing market. An increase in the awareness about treatments and R & D investment by the companies for developing new techniques and acquiring other companies is expected to increase demand for neurogenetic testing during the forecast period.
COVID-19 had an impact on the neurogenetic testing market. The funds from the government increased during this time for research. But these funds were utilized for researching Sars Cov 2 genomics. This impacted the screening and many early signs of neurological disorders went undetected.
During this pandemic times, the hospitals started giving neurogenetics counselling through telephone videoconferencing (telegenetics) for remote places. However, this pandemic has allowed researchers to come up with new techniques for neurogenetic testing. The market had an overall negative impact due to COVID-19.
Some of the leading manufacturers of neurogenetic testing include
The region that is dominating the neurogenetics testing market is North America with countries like the US and Canada. These countries have increased their healthcare spending and has the presence of major players. Also, advancements in DNA sequencing techniques, increase in research funding by the government are driving factors for the market.
Followed by North America, the region that is expected to dominate the market is Asia. This is because of increase in prevalence of neurological disorders in this region. According to a report, the prevalence of neurological disorders are higher in low and middle income countries. Apart from this, the advancements in the DNA sequencing technique and an increase in life science research are driving the market.
By Technique
By End-user
By Region
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
To know more about delivery timeline for this report Contact Sales
